Therapeutics for the treatment of coronavirus disease 2019 in children and adolescents
Coronavirus disease 2019 (COVID-19) is a mild to moderate respiratory illness in most children and adolescents, but a small proportion develop severe or critical illness. Although pediatric clinical trials for the treatment of COVID-19 are sparse, there are some available drugs for children and adol...
Saved in:
Main Authors: | Soo-Han Choi (Author), Jae Hong Choi (Author), Ki Wook Yun (Author) |
---|---|
Format: | Book |
Published: |
The Korean Pediatric Society,
2022-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effects of nonpharmaceutical interventions for coronavirus disease 2019
by: Jae Hong Choi
Published: (2022) -
Epidemiology and clinical features of coronavirus disease 2019 in children
by: Soo-Han Choi, et al.
Published: (2020) -
Updates on the coronavirus disease 2019 vaccine and consideration in children
by: Hyun Mi Kang, et al.
Published: (2021) -
Clinical features, diagnosis, and outcomes of multisystem inflammatory syndrome in children associated with coronavirus disease 2019
by: Ji Hee Kwak, et al.
Published: (2021) -
The coronavirus disease 2019 infodemic: a concept analysis
by: Sujin Choi
Published: (2024)